Katalyst makes FDA-approved full-body, wearable electro muscle stimulation products used for health and fitness. The company plans to use the new funding to scale production, develop its brand and hire new employees, according to the Oct. 4 Katalyst news release.
“As an industry, we’ve struggled to innovate in ways that actually empower the vast majority of our population to live longer, healthier, and happier lives,” Katalyst founder and CEO Bjoern Woltermann said. “Katalyst eliminates the external loads and physical wear associated with conventional workouts, as well as the significant time required, making fitness easier, faster, safer, and more effective than ever before. I was first introduced to full-body EMS training in Germany in 2012, and I realized immediately that this technology, outside the confines of a physical studio, had the potential to significantly improve quality of life and overall well-being on a mass scale.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.